¢¨Ëè½µ²ÐÍˤËÎØÆɲñ¡¦¸¦µæ²ñ¤ò¤·¤Æ¤¤¤Þ¤¹¡£¡Ê³°Éô»²²Ã²Äǽ¡£ ¤´ÁêÃ̲¼¤µ¤¤¡Ë¡¡
²¼µ¤¤¤º¤ì¤«£²¤Ä
10:00-11:00 | 11:00-12:00 | ||||||
ÆüÄø | ¾ì½ê | ôÅö | ¼ïÊÌ | ¥¿¥¤¥È¥ë | ôÅö | ¼ïÊÌ | ¥¿¥¤¥È¥ë |
4/15 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ¥ª¥ê¥¨¥ó¥Æ¡¼¥·¥ç¥ó | |||||
4/22 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ¾åÌî | ¸¦µæ | 2·¿ÅüǢɴµ¼Ô¤Î¥Ø¥ë¥¹¥ê¥Æ¥é¥·¡¼¤È¼«¸Ê´ÉÍý¤Ë´Ø¤¹¤ë¸¦µæ | ÀÐÀî | ²Ê¸¦¥×¥í¥¸¥§¥¯¥È¾Ò²ð 11:30¡Á¶µ¼¼´¿·Þ²ñ | |
4/29 | µÙ¤ß | ||||||
5/6 | µÙ¤ß | ||||||
5/13 | ´ÉÍý¸¦µæÅï2FÂè3²ñµÄ¼¼ | »°±º | ¸¦µæ | ³°¹ñ¿Í´µ¼Ô¼õÆþ¤ì°åÎŵ¡´Øǧ¾ÚÀ©ÅÙ(JMIP) | ·êÂô | ¸¦µæ | °åÎÅÄÌÌõ´ØÏ¢¤Î¸¦µæ¤Î¾Ò²ð |
5/20 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ²¬ÅÄ | ¸¦µæ | ¤¬¤óÎ×¾²»î¸³¤Î¥¤¥ó¥Õ¥©¡¼¥à¥É¥³¥ó¥»¥ó¥È¤Ë¤ª¤±¤ë¥¿¥Ö¥ì¥Ã¥ÈüËö¤Î±þÍÑ | ÌÚÆâ | °å³Ø¸¦µæ¤ÈCDISCɸ½à | |
5/27 | ´ÉÍý¸¦µæÅï2FÂè3²ñµÄ¼¼ | ±ü¼ | ¸¦µæ | ÆüËܤοÇÎÅ¥¬¥¤¥É¥é¥¤¥óºîÀ®Æ°¸þ¤Ë´Ø¤¹¤ëÄ´ººÊó¹ð | ¸¶ÌÚ | ¸¦µæ | Theoretical Framework¤Î¸¡Æ¤ |
6/3 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ±ü¸¶ | ¸¦µæ | ¥Ø¥ë¥¹¥±¥¢Ê¸½ñ¤ÎŬÀÚÀɾ²Á¼ÜÅ٤ο®ÍêÀ¸¡¾Ú¤ª¤è¤Ó¶èÊ󤬤󸡿ǵ»ö¤Îɾ²Á | òîÌî | ÀºÆÉ | Effective Doctor-Patient Communication: An Upldated Examination ¡úhttp://www.ncbi.nlm.nih.gov/pubmed/24802220 |
6/10 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | µÙ¤ß | |||||
6/17 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ¸¶ÌÚ | ÏÀʸÀºÆÉ | Crowdsourcing Applications for Public Health ¡úhttp://www.sciencedirect.com/science/article/pii/S0749379713005898# | »°±º | ¸¦µæ | Àº¿À²Ê°åÎŤˤª¤±¤ë°åÎÅÄÌÌõ¼Ô¤Î¸½¾õ¤È²ÝÂê¤Ë´Ø¤¹¤ëÄ´ºº |
6/24 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ±ü¼ | ¸¦µæ | ¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥óÆâÍÆʬÀÏ | ÀÐÀî | ÏÃÂêÄó¶¡ | °å³Ø¶µ°é³Ø²ñ¥Ñ¥Í¥ë¥Ç¥£¥¹¥«¥Ã¥·¥ç¥ó¡Ö°å³Ø¶µ°é¸¦µæ¤Ï¤¸¤á¤Î°ìÊ⡧ÏÀʸ¼¹É®¤Ë¸þ¤±¤¿12Tips¡×¾Ò²ð |
7/1 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ²¬ÅÄ | ÎØÆÉ | Chapter3 Patient-Caregiver Communication | |||
7/8 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ¾åÌî | ¸¦µæ | 2·¿ÅüǢɴµ¼Ô¤Î¥Ø¥ë¥¹¥ê¥Æ¥é¥·¡¼¤È¼«¸Ê´ÉÍý¤Ë´Ø¤¹¤ë¸¦µæ·ë²ÌÊó¹ð¢ | »°±º | ¸¦µæ | Àº¿À²Ê°åÎŤˤª¤±¤ëÄÌÌõ¤ÇɬÍפʤ³¤È¡Êʸ¸¥¥ì¥Ó¥å¡¼¡Ë |
7/15 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ¸¶ÌÚ | ±ü¼ | ¸¦µæ | |||
7/22 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ͽÈ÷Æü |
13:00-14:00 | |||
ÆüÄø | ¾ì½ê | ôÅö | ¸¦µæÂêÌÜ |
6/3 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ||
6/10 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ||
6/17 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ||
6/24 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ||
7/1 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ||
7/8 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ||
7/15 | ´ÉÍý¸¦µæÅï2FÂè2²ñµÄ¼¼ | ||
9/2 | UMIN²ñµÄ¼¼ | ¸¶ÌÚ¡¦²¬ÅÄ | ¥Ø¥ë¥¹¥³¥ß¥å¥Ë¥±¡¼¥·¥ç¥ó³Ø²ñȯɽͽ¹Ô |